ADVERTISEMENT

APhA Policy Manual

Use of Representative Populations in Clinical Studies


  1. APhA supports the use of representative populations in clinical studies, including, but not limited to protected populations such as women, persons who are underrepresented or historically marginalized, older adults, persons who are transgender and gender-diverse, and children when appropriate.
  2. APhA encourages the development of research techniques which would identify possible problems not readily detected in adult clinical investigations to aid in the safe and effective evaluation of drugs in children.
Advertisement
Advertisement